Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open Label Study of Sofosbuvir/GS-5816 in Chronic HCV Infection
2014-003898-42Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sofosbuvir and velpatasvir in chronic hepatitis C (CHC), sponsored by Gilead Sciences. Primary endpoint: SVR12. Started Dec 2014; status: completed.
02
Drugs
sofosbuvirvelpatasvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2014-003898-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003898-42.